Across
- 4. Acronym for gene expression profiling guiding melanoma and SCC management.
- 6. Focus of the 2024 Incyte Ingenuity Awards promoting advocacy and innovation.
- 8. Type of aesthetic approach favored over quick fixes, per Robin Smith, MD.
- 9. Biologic studied in the ADmirable trial for efficacy in skin of color.
- 12. (Abbreviation) Skin cancer subtype discussed in GEP-guided treatment strategies.
- 13. Ongoing issue among dermatology trainees despite pandemic recovery.
- 14. (Abbreviation) Imaging technology enhanced by e-learning for better BCC diagnosis.
- 16. Chronic disease examined in recent cost-effectiveness studies.
Down
- 1. Castle Biosciences’ trial on cSCC featuring PA involvement in research roles.
- 2. Topical treatment showing promise for sensitive skin areas in atopic dermatitis.
- 3. Injectable gel under FDA review for use on neck lines.
- 5. Aesthetic concern addressed by lebrikizumab in patients with skin of color.
- 7. Dermatologist featured in a Q&A on biologics and patients with skin of color.
- 10. Tiny vesicles powering regenerative aesthetics in Robin Smith, MD’s Exoceuticals brand.
- 11. Alphyn Biologics' hydrogel that targets inflammation, itch, and bacteria in AD.
- 15. (Abbreviation) Submission type filed to expand aesthetic injectable's indication to neck treatment.